Nagoya, Japan

Tomohiko Ishikawa


Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 34(Granted Patents)


Location History:

  • Showa-ku, Nagoya-shi, Aichi-ken, JP (1991)
  • Nogoya, JP (1992)
  • Nagoya, JP (1993)

Company Filing History:

goldMedal2 out of 5 
 
Tobishi Yakuhin Kogyo Kabushiki Kaisha
 patents
silverMedal5 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1991-1993

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Tomohiko Ishikawa

Introduction

Tomohiko Ishikawa is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on developing innovative compounds that address various medical conditions.

Latest Patents

Ishikawa's latest patents include an anti-ulcer agent that contains a compound expressed by a specific general formula. This compound is designed to alleviate ulcer symptoms effectively. Another significant patent involves novel quinoline sulfonamino derivatives that exhibit vessel smooth muscle relaxation activity. These derivatives also demonstrate platelet agglutination inhibitory activity and have minimal effects on cardiac function, making them valuable in pharmaceutical applications.

Career Highlights

Throughout his career, Ishikawa has worked with various companies, including Tobishi Yakuhin Kogyo Kabushiki Kaisha. His innovative approach and dedication to research have led to the development of important pharmaceutical products.

Collaborations

Ishikawa has collaborated with notable coworkers such as Tsutomu Inoue and Osamu Sakuma. Their combined expertise has contributed to the advancement of their projects and the successful development of new compounds.

Conclusion

Tomohiko Ishikawa's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…